Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
01/2002
01/02/2002EP1165547A1 Substituted benzoylpyrazoles as herbicides
01/02/2002EP1165545A1 Novel compounds
01/02/2002EP1165542A1 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands
01/02/2002EP1165540A1 Tetrahydropyran derivatives and their use as therapeutic agents
01/02/2002EP1165514A1 3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors
01/02/2002EP1165505A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
01/02/2002EP1165071A2 Improved cancer treatment with temozolomide
01/02/2002EP0983273B1 Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents
01/02/2002EP0815117B1 C-nucleoside derivatives and their use in nucleic acid detection
01/02/2002EP0785938B1 Fused pyrrolocarbazoles
01/02/2002CN1329614A Fused pyridazine derivatives, process for preparation of same and uses thereof
01/02/2002CN1329284A Colour coupler and silver halide colour photographic photosensitive material
01/02/2002CN1329281A Colour photosensitive imaging element containing closed developer
01/02/2002CN1329002A Intermediate product for preparing aralkyl and aryl alkylene heterocyclic lactam and imide
01/02/2002CN1328824A Compound for curing female sexual disorder
01/02/2002CN1077109C S type 2-substituted hydroxy 2-indolidinylbutyric ester compounds and process for preparation thereof
01/02/2002CN1077108C Precursor compound for preparing medicine 'xiduofen'
01/01/2002US6335442 Phthalocyanines
01/01/2002US6335358 Lactacystin analogs
01/01/2002US6335356 Method of treating a patient by parenteral administration of a lipophilic compound
01/01/2002US6335344 Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases
01/01/2002CA2142869C Trifluoromethylpyrroloindolecarboxylic acid ester and process for production thereof
01/01/2002CA2067741C 10(1-hydroxyethly)-11-oxo-1-azatricyclo[7.2.0.0.3.8]undec-2-ene-2-carboxylic acid esters and a process for preparing thereof
12/2001
12/27/2001WO2001098305A1 PROCESS FOR THE PREPARATION OF 2-AMINO-5,8-DIMETHOXY[1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE
12/27/2001WO2001098304A1 A process for preparing pyrazolopyrimidinone derivatives for the treatment of impotence
12/27/2001WO2001098303A1 Novel process for the preparation of pyrazolopyrimidinones
12/27/2001WO2001098302A1 Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer
12/27/2001WO2001098284A1 Process for the preparation of pyrazolopyrimidinones
12/27/2001WO2001097787A2 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl)
12/27/2001WO2001057042A3 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy
12/27/2001WO2001032646A3 Sulfonamide derivatives
12/27/2001WO2001023390A3 Azepinoindole derivatives, the production and use thereof
12/27/2001CA2413277A1 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl)
12/26/2001CN1328560A [1,2,4] triazolo [1,5-c] pyrimidine derivatives
12/26/2001CN1328559A CRF receptor antagonists and methods relating thereto
12/26/2001CN1328461A Method for preventing/treating damage to sensory hair cells and cochlear neurons
12/26/2001CN1328451A Drugs for improving vesical excretory strength
12/26/2001CN1327793A Pyrrolo-triazine and pyrimidine compounds
12/26/2001CN1076744C Monophase solid solution containing asymmetric pyrrolo [4,3-C] pyrroles as hosts
12/25/2001US6333521 Oleds containing thermally stable glassy organic hole transporting materials
12/25/2001US6333425 Ionic compounds derived from malononitrile in which anionic charge is delocalized; excellent properties of solubility and dissociation
12/25/2001US6333344 Prolines as antimicrobial agents
12/25/2001US6333331 Useful in inactivating the human dna repair protein o.sup.6 -alkylguanine-dna alkyltransferase; anticancer agents
12/25/2001US6333330 Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction
12/25/2001US6333319 Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof
12/25/2001US6333296 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them
12/25/2001US6333044 For therapy of inflammation and pain of a traumatic or pathologic origin
12/20/2001WO2001096345A1 Tetrapyrroles
12/20/2001WO2001096343A1 Substituted metal-phthalocyanines, their preparation and the use thereof
12/20/2001WO2001096341A2 Fungicidal triazolopyrimid-7-ylideneamines
12/20/2001WO2001096336A2 6,5-fused bicyclic heterocycles
12/20/2001WO2001096318A1 Cyclic urea compounds and preparation thereof
12/20/2001WO2001096314A1 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
12/20/2001WO2001096313A1 Distamycin a analogs
12/20/2001WO2001096282A1 Method for producing amides or esters
12/20/2001WO2001087838A8 Cyclohexane derivatives and their use as therapeutic agents
12/20/2001WO2001074788A8 2-hydroxy-mutilin carbamate derivatives for antibacterial use
12/20/2001WO2001066550A3 Compounds for pdt
12/20/2001WO2001049689A3 NOVEL SUBSTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM
12/20/2001WO2001042391A3 A new family of conducting liquid crystals
12/20/2001WO2001022969A3 Vasopressin agonist formulation and process
12/20/2001US20010053782 Pyrrolo[2,3-d]pyrimidine compounds
12/20/2001US20010053776 Tricyclic pyridin-2-one analogue as a GABA receptor ligand
12/20/2001US20010053463 OLEDs doped with phosphorescent compounds
12/20/2001CA2778314A1 Cyclic urea compounds and preparation thereof
12/20/2001CA2412623A1 Tetrapyrroles
12/20/2001CA2412462A1 6,5-fused bicyclic heterocycles
12/20/2001CA2412010A1 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
12/19/2001EP1164418A2 Color photothermographic elements comprising blocked developing agents
12/19/2001EP1164136A1 Long wavelength absorbing bacteriochlorin alkyl ether analogs
12/19/2001EP1164135A1 Substituted metal-phthalocyanines, their preparation and the use thereof
12/19/2001EP1163247A1 Pharmaceutical compositions comprising metal complexes
12/19/2001EP1163242A2 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
12/19/2001EP1163238A1 Chemokine recpetor binding heterocyclic compounds
12/19/2001EP1094816A4 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/19/2001EP0828742B1 Diazepino-indoles as phosphodiesterase iv inhibitors
12/19/2001EP0781281B1 Beta-carboline derivatives as melatonin agonists, methods for their preparation and their use as drugs
12/19/2001CN1326803A Reaction crystallizing method for improving grain size
12/19/2001CN1076369C Solid solutions of 1,4-diketopyrrbopyrroles
12/18/2001US6331640 Diaminopropionic acid derivatives
12/18/2001US6331636 Treatment of central nervous system disorders, diabetes, hypertension, impotency, appetite control
12/18/2001US6331543 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
12/18/2001US6331507 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
12/18/2001CA2018769C Adduct-aldehyde and its use for the preparation of a vitamin-d compound
12/13/2001WO2001094351A1 Caspase inhibitors and uses thereof
12/13/2001WO2001094350A1 6-phenylpyrrolopyrimidinedione derivatives
12/13/2001WO2001093841A2 Barbituric acid analogs as therapeutic agents
12/13/2001WO2001072667A3 Modifying chemoselectivity during oxidation of nitrogen compounds
12/13/2001WO2001049275A3 Methods and compositions for mitigating pain using nitrate esters
12/13/2001US20010051722 Aminoaryl Oxazolidinone N-oxides
12/13/2001US20010051622 5HT2C Receptor agonists to treat schizophrenia and central nervous system disorders; obsessive-compulsive disorder; antidepressants, migraine; sleep disorders; eating disorders; obesity; antidiabetic, -epileptic and anxiolytic agents
12/13/2001CA2411013A1 6-phenylpyrrolopyrimidinedione derivatives
12/13/2001CA2409015A1 Caspase inhibitors and uses thereof
12/13/2001CA2345195A1 Color photothermographic elements comprising blocked developing agents
12/12/2001EP1162504A2 Coupler and silver halide color photographic light-sensitive material
12/12/2001EP1161949A1 Use od diazepinoindoles for the treatment of chronic obstructive pulmonary disease
12/12/2001EP1161433A1 Tyrosine kinase inhibitors
12/12/2001EP1161423A1 Thiazolyl urea derivatives and their utilization as antiviral agents
12/12/2001EP1161244A2 Use of 1,2,4-triazolo[1,5-a]pyrimidine derivatives for treating migraine
12/12/2001EP1161243A2 Pharmaceutical compositions comprising a pyrimidine derivative and cyclodextrin